Gene Expression and Ketamine Response in Subjects With Treatment-Resistant Depression

被引：0
|
作者：
Mohazzab-Hosseinian, Sahra [1 ]
Kadriu, Bashkim [1 ]
Zandi, Peter [1 ]
Zarate, Carlos [1 ]
Goes, Fernando [1 ]
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Biomarker; Ketamine; Treatment Resistant Depression;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T164
引用
收藏
页码：318 / 319
页数：2
相关论文
共 50 条
  • [21] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [22] The role of intranasal ketamine in treatment-resistant depression
    Costa, M.
    Fraga, M.
    Moutinho, A.
    Cintra, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
  • [23] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [24] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [25] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [26] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [27] Oral ketamine for the treatment of pain and treatment-resistant depression
    Schoevers, Robert A.
    Chaves, Tharcila V.
    Balukova, Sonya M.
    aan het Rot, Marije
    Kortekaas, Rudie
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
  • [28] Intravenous subanesthetic ketamine: an innovative treatment option for rapid response in treatment-resistant depression
    Kang, M.
    Hawken, E.
    Bahji, A.
    Brietzke, E.
    Vazquez, G.
    EUROPEAN PSYCHIATRY, 2020, 63 : S113 - S113
  • [29] Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression
    Singh, Balwinder
    Voort, Jennifer L. Vande
    Riva-Posse, Patricio
    Pazdernik, Vanessa M.
    Frye, Mark A.
    Tye, Susannah J.
    BIOLOGICAL PSYCHIATRY, 2023, 93 (12) : E65 - E68
  • [30] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    James W. Murrough
    Le-Ben Wan
    Brian Iacoviello
    Katherine A. Collins
    Carly Solon
    Benjamin Glicksberg
    Andrew M. Perez
    Sanjay J. Mathew
    Dennis S. Charney
    Dan V. Iosifescu
    Katherine E. Burdick
    Psychopharmacology, 2014, 231 : 481 - 488
12345